dronabinol has been researched along with Leukemia, Lymphocytic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisher, M; Grant, S; Lombard, C; Martin, BR; McKallip, RJ; Nagarkatti, M; Nagarkatti, PS; Ryu, S | 1 |
1 other study(ies) available for dronabinol and Leukemia, Lymphocytic
Article | Year |
---|---|
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cannabinoids; Cell Survival; Dose-Response Relationship, Drug; Dronabinol; Drug Evaluation, Preclinical; Humans; Leukemia, Lymphoid; Ligands; Mice; Mice, Inbred C57BL; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Cannabinoid; Receptors, Drug; Survival Rate; Treatment Outcome; Tumor Cells, Cultured | 2002 |